Clinical trial
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8…
NCT00035828 · Abgenix, Industry · Completed
Key facts
| NCT number | NCT00035828 |
|---|---|
| Title | A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD |
| Lead sponsor | Abgenix, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic |
| Intervention type | Drug |
| Interventions | ABX-IL8 |
| Enrollment | 150 |
| Start date | Dec 1, 2001 |
| Completion | Dec 1, 2002 |
| First posted | May 7, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: